Cytoo

About:

Cytoo develops and distributes products that make cellular analysis robust and reliable by dramatically decreasing cell variability.

Website: http://www.cytoo.com

Twitter/X: CYTOO

Top Investors: Auriga Partners, Entrepreneurs Fund, CEA Investissement, Rhone-Alpes Creation, Jacques Lewiner

Description:

CYTOO focuses on innovative products for the life science research market with an emphasis in cell based assays, high content analysis and cell screening. They develop, manufacture, and distribute products that make cellular analysis robust and reliable by dramatically decreasing cell variability. There new micropattern-based products are designed to meet the needs of all clients whatever their research goals. They are open to suggestions or specific requests that can improve and spread the scope of this breakthrough in quantitative cell analysis.

Total Funding Amount:

$16.2M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Grenoble, Rhone-Alpes, France

Founded Date:

2008-01-01

Contact Email:

contact(AT)cytoo.com

Founders:

François Chatelain

Number of Employees:

11-50

Last Funding Date:

2011-11-25

IPO Status:

Private

Industries:

© 2025 bioDAO.ai